Morsa Images/DigitalVision via Getty Images Introduction I last wrote about Elevance Health (NYSE:ELV) on October 23, 2023, in my article "Elevance Health: An Overlooked Healthcare Gem?". Since then, ELV has reported three quarters of earnings while underperforming the S&P 500 by around 9% (S&P gain: 28.9% / ELV gain: 19.8%). I initiated coverage on ELV with a "buy" rating back then. Recent results, especially around the healthcare services segment, led me to this update article. In this article, I want ...